Literature DB >> 12806380

Gyrus bipolar electrovaporization vs transurethral resection of the prostate: a randomized prospective single-blind trial with 1 y follow-up.

W D Dunsmuir1, J P McFarlane, A Tan, C Dowling, J Downie, J Kourambas, S Donnellan, N Redgrave, R Fletcher, M Frydenberg, C Love.   

Abstract

The Gyrus system uses bipolar electrocautery with saline irrigation to vaporize prostatic tissue and is compared to transurethral resection of the prostate (TURP) in a randomized prospective study with 1 y follow-up. Outcomes measured were fluid absorption, blood loss, period of catheterization, hospital stay, symptom scores, quality of life, flow rates, and post-void residual volumes at 3, 6, and 12 months. All measured parameters were similar, although re-catheterization rates were higher (30% vs 5%) in the Gyrus group. Clot evacuation rates were higher in the TURP group (19% vs 0%). The Gyrus device is safe and produces results that are similar to TURP at 1 y.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12806380     DOI： 10.1038/sj.pcan.4500631

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN： 1365-7852            Impact factor:   5.554


  16 in total

1.  Bipolar vaporization of the prostate: is it ready for the primetime?

Authors:  Viorel Bucuras; Razvan Bardan
Journal:  Ther Adv Urol       Date:  2011-12

2.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

3.  [Benign prostate hyperplasia].

Authors:  U Jonas; A I Gabouev; T R W Herrmann; K Höfner; M C Michel; M Alschibaja; R Hartung
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

4.  Management of urinary incontinence.

Authors:  George A Demaagd; Timothy C Davenport
Journal:  P T       Date:  2012-06

5.  [Transurethral resection of the prostate and current modifications (bipolar, electrovaporization)].

Authors:  R Muschter; T Bach; M Seitz
Journal:  Urologe A       Date:  2013-03       Impact factor: 0.639

Review 6.  Bipolar plasma vaporization of the prostate: ready to replace GreenLight? A systematic review of randomized control trials.

Authors:  Grégoire Robert; Alexandre de la Taille; Thomas Herrmann
Journal:  World J Urol       Date:  2014-08-27       Impact factor: 4.226

7.  [Benign prostatic syndrome (BPS). Ablative treatments].

Authors:  O Reich; M Seitz; C Gratzke; B Schlenker; A Bachmann; C Stief
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

8.  Transurethral resection of the prostate with a bipolar tissue management system compared to conventional monopolar resectoscope: one-year outcome.

Authors:  Chang-Jun Yoon; Ji-Yoon Kim; Ki-Hak Moon; Hee-Chang Jung; Tong-Choon Park
Journal:  Yonsei Med J       Date:  2006-10-31       Impact factor: 2.759

9.  Comparative outcomes of plasmakinetic versus monopolar transurethral resection of benign prostatic hyperplasia: 7 years' results.

Authors:  Sakıp Erturhan; Ömer Bayrak; İlker Seçkiner; Asaf Demirbağ; Ahmet Erbağcı; Faruk Yağcı
Journal:  Turk J Urol       Date:  2013-12

10.  Plasmakinetic vaporization versus transurethral resection of the prostate: Six-year results.

Authors:  Orhan Koca; Muzaffer Oğuz Keleş; Cevdet Kaya; Mustafa Güneş; Metin Öztürk; Muhammet İhsan Karaman
Journal:  Turk J Urol       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.